Patents by Inventor Zuopeng Sun

Zuopeng Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1H-IMIDAZO [4,5-H] QUINAZOLINE COMPOUND AS NOVEL SELECTIVE FLT3 INHIBITORS
    Publication number: 20230312583
    Abstract: Provided is a 1H-imidazo [4,5-h] quinazoline compound of formula (I). The compound is a broad spectrum inhibitor having strong activity for FLT3 kinase, and is applicable in treating cell proliferative disorders.
    Type: Application
    Filed: August 27, 2021
    Publication date: October 5, 2023
    Inventors: Chengzhi Yu, Zuopeng Sun, Bin Liu, Chenggang Zhang
  • NOVEL COMPOUNDS AS INHIBITORS OF PCSK9
    Publication number: 20230122967
    Abstract: Disclosed are a compound of formula (I), wherein the variables are defined in the specification, a pharmaceutical composition containing the same, and a method and a use of the compound or composition in the treatment of a PCSK9-mediated disease such as cardiovascular disease.
    Type: Application
    Filed: January 14, 2021
    Publication date: April 20, 2023
    Inventors: Soan Cheng, Chengzhi Yu, Zuopeng Sun, Chenggang Zhang